Transplantation Proceedings

Foreword
pp. 2195-2195(1)
Author: Lloveras J.

The Gold Medal of the Catalan Transplantation Society to Professors J.M. Gil-Vernet and A. Caralps
pp. 2199-2200(2)
Author: Lloveras J.

Tacrolimus in solid organ transplantation: an update
pp. 2203-2205(3)
Author: Shapiro R.

Daclizumab: novel biologic immunoprophylaxis for prevention of acute rejection in renal transplantation
pp. 2206-2207(2)
Author: Vincenti F.

Current use of polyclonal antilymphocyte antibody preparations
pp. 2208-2209(2)
Author: Merion R.M.

Use of steroids in renal transplantation
pp. 2210-2211(2)
Authors: Ponticelli C.; Tarantino A.; Montagnino G.; Vegeto A.

Corticosteroid withdrawal after heart transplantation
pp. 2212-2214(3)
Authors: Vazquez de Prada J.A.; Celemn I.; de la Torre J.M.; Rodriguez F.; Sanchez N.; Riesco F.; Herrero C.; Ruano J.; Olalla J.; Martn-Duran R.

Non-heart-beating donors and emergency health care systems
pp. 2215-2216(2)
Authors: Alvarez J.; Del Barrio R.; Arias J.; Cuesta C.; Crespo P.; Bilbao J.; Soria L.; Barra C.; Iglesias J.; Elvira J.

Ischemia and reperfusion injury in transplantation
pp. 2217-2218(2)
Authors: Torras J.; Cruzado J.M.; Grinyo J.M.

Transplant vasculopathy in early protocol renal allograft biopsies
pp. 2219-2220(2)
Authors: Seron D.; Moreso F.

Hepatitis C virus infection and renal transplantation
pp. 2221-2224(4)
Author: Morales J.M.

Infection in xenotransplantation: a clinical approach
pp. 2225-2227(3)
Author: Fishman J.A.

Genetic engineering approaches for organ transplantation
pp. 2228-2229(2)
Authors: Aran J.M.; Fillat C.; Estivill X.

Tools of gene transfer in organ transplantation
pp. 2230-2231(2)
Authors: Fillat C.; Aran J.M.; Estivill X.

Latin American Organ Transplant Registry
pp. 2232-2234(3)
Authors: Santiago Delpn E.A.; Duro Garca V.

Development of regional transplant programs
pp. 2235-2238(4)
Authors: Garcia V.D.; Goldani J.C.; Dominguez V.; Michelon T.; Neumann J.; Keitel E.

Collecting system dilatation of kidney grafts: causes and value of serial ultrasonographic studies in the differential diagnosis
pp. 2241-2243(3)
Authors: Salgado O.; Martn M.; Urdaneta B.; Garca R.; Rodrguez-Iturbe B.

Efficacy of renal vascular embolization versus surgical nephrectomy in the treatment of nonfunctioning renal allografts
pp. 2244-2245(2)
Authors: Cofan F.; Vilardell J.; Gutierrez R.; Real M.; Montanya X.; Oppenheimer F.; Talbot-Wright R.; Carretero P.

Population pharmacokinetics of cyclosporine in kidney transplant patients
pp. 2246-2247(2)
Authors: Porta B.; Perez-Ruixo J.J.; Gorriz J.L.; Crespo J.F.; Sancho A.; Pallardo L.M.; Jimenez N.V.

Conversion from cyclosporine to FK 506 as rescue therapy in renal transplantation with poorly steroid-responsive acute rejection
pp. 2248-2249(2)
Authors: Morales E.; Andres A.; Herrero J.C.; Dominguez-Gil B.; Carreno A.; Morales J.M.; Hernandez E.; Ortuno T.; Praga M.

Acute tacrolimus nephrotoxicity in renal transplant patients treated with clarithromycin
pp. 2250-2251(2)
Authors: Gomez G.; Alvarez M.L.; Errasti P.; Lavilla F.J.; Garca N.; Ballester B.; Garca I.; Purroy A.

Clinical management of Tacrolimus drug interactions in renal transplant patients
pp. 2252-2253(2)
Authors: Moreno M.; Latorre A.; Manzanares C.; Morales E.; Herrero J.C.; Dominguez-Gil B.; Carreno A.; Cubas A.; Delgado M.; Andres A.; Morales J.M.

Depleting effect of antithymocyte globulin on T-lymphocyte subsets in kidney transplantation
pp. 2254-2255(2)
Authors: Mestre M.; Bas J.; Alsina J.; Grinyo J.M.; Buendia E.

Induction treatment with mycophenolate mofetil, cyclosporine, and low-dose steroids with subsequent early withdrawal in renal transplant patients: results of the Spanish group
pp. 2256-2258(3)
Author: Puig i Mar J.M.

Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients
pp. 2259-2260(2)
Authors: Puig J.M.; Lloveras J.; Fernandez-Crespo P.; Mir M.; Inigo V.; Manresa J.M.; Masramon J.

Triple therapy with mycophenolate mofetil, cyclosporine, and prednisone in renal transplantation
pp. 2261-2262(2)
Authors: Crespo J.F.; Gorriz J.L.; Sancho A.; Avila A.; Alcoy E.; Pallardo L.M.

Mycophenolate mofetil, cyclosporine, and steroids after renal transplantation: five-year results at a single center
pp. 2263-2264(2)
Authors: Herrero J.C.; Morales E.; Dominguez-Gil B.; Carreno A.; Cubas A.; Andres A.; Praga M.; Ortuno T.; Hernandez E.; Rodicio J.L.; Morales J.M.

The early impact of mycophenolate mofetil in combination with steroids and cyclosporine neoral after renal transplantation: a six-month analysis
pp. 2265-2266(2)
Authors: Cubas A.; Herrero J.C.; Morales E.; Carreno A.; Dominguez-Gil B.; Cirujeda A.; Praga M.; Ortuno T.; Hernandez E.; Delgado M.; Andres A.; Morales J.M.

Mycophenolate mofetil slows the decline of renal function in patients with biopsy-proven chronic rejection: a collaborative pilot study
pp. 2267-2269(3)
Authors: Campistol J.M.; Mazuecos A.; Segura J.; Osuna A.; Herrero J.C.; Andres A.; Oppenheimer F.; Gomez de la Camara A.; Martinez M.A.; Morales J.M.

Risk factors that influence the incidence and severity of MMF adverse events in renal transplant patients: relationship with corticosteroid dosage, renal function, sex, and patient age
pp. 2270-2271(2)
Authors: Puig J.M.; Fernandez-Crespo P.; Lloveras J.; Mir M.; Inigo V.; Manresa J.M.; Masramon J.

Treatment with mycophenolate mofetil in kidney transplant patients with organs from donors aged over 60 years: - One-year monitoring results
pp. 2272-2274(3)
Authors: Agraz I.; Guirado L.; Andrade M.; Olaya M.; Vila A.; Sola R.

Mycophenolic acid monitoring: evaluation of the EMIT MPA immunoassay in kidney and lung transplantation
pp. 2275-2276(2)
Authors: Brunet M.; Oppenheimer F.; Martorell J.; Vilardell J.; Carreno M.C.; Carrillo M.; Corbella J.

Should aging recipients of kidney grafts receive less immunosuppression?
pp. 2277-2278(2)
Authors: Palomar R.; Ruiz J.C.; Escallada R.; Rodrigo E.; Cotorruelo J.; Heras M.; Zubimendi J.A.; Arias M.

The replacement of azathioprine by mycophenolate mofetil in pediatric patients with specific risks in renal transplantation
pp. 2279-2279(1)
Authors: Anguita A.; Repetto H.A.; Rodriguez-Rilo L.; Vazquez L.A.; Iturzaeta A.; Morrone G.; Deheza R.; Maldonado L.; Goldberg J.L.

The effect of different immunosuppression on the outcome of pediatric renal transplants
pp. 2280-2280(1)
Authors: Garca Meseguer C.; Alonso A.; Vanegas J.J.; Martinez Debora M.J.; Navarro M.

Long-term results of renal transplants from donors older than 60 years
pp. 2281-2282(2)
Authors: Herrero J.C.; Andres A.; Praga M.; Morales E.; Dominguez-Gil B.; Carreno A.; Hernandez E.; Morales J.M.

Apoptosis and proliferation index in renal biopsies with early chronic rejection and in biopsies from donors older than 60 years
pp. 2283-2284(2)
Authors: Pardo F.J.; Errasti P.; Idoate M.A.; Sola I.; Lozano M.D.; de Alava E.; Panizo A.

The double or single renal graft depending on the percentage of glomerulosclerosis in the preimplant biopsy reduces the number of discarded kidneys from donors older than 60 years
pp. 2285-2286(2)
Authors: Andres A.; Herrero J.C.; Morales E.; Praga M.; Vazquez S.; Vereda M.; Cebrian P.; Rodicio J.L.; Morales J.M.; Aguirre F.; Diaz R.; Polo G.; Leiva O.

Double kidney transplant
pp. 2287-2289(3)
Authors: Riera L.; Seron D.; Franco E.; Suarez J.F.; Fulladosa X.; Ramos R.; Gil-Vernet S.; Condom E.; Gonzalez C.; Grinyo J.M.; Serrallach N.

Influence of donor age on Doppler spectrum in the early phase of renal transplantation
pp. 2290-2290(1)
Authors: Ruiz J.C.; Gonzalez A.; Pereda T.; Lopez-Rasines G.; Calabia A.; Rodrigo E.; Pinera C.; Arias M.

Kidneys not acceptable for transplant
pp. 2291-2291(1)
Authors: Gonzalez Segura C.; Tormos P.; Torras J.; Pascual M.; Riera L.; Suarez Novo J.F.; Garcia Huete L.; Sabate I.

Preservation of kidneys from marginal donors with pulsatile perfusion machine
pp. 2292-2293(2)
Authors: Suarez J.F.; Riera L.; Franco E.; Ruiz R.; Roig M.; Torras J.; Gonzalez C.; Grinyo J.M.; Serrallach N.

Kidney transplantation with living donors: better long-term survival
pp. 2294-2295(2)
Authors: Melchor J.L.; Gracida C.

Renal transplantation and graft survival and its influencing factors
pp. 2296-2300(5)
Authors: Agraz I.; Guirado L.L.; Lopez-Navidad A.; Caballero P.; Andrade M.; Vila A.; Sola R.

Factors related to allograft survival in recipients of the same donor
pp. 2301-2301(1)
Authors: Cubero J.J.; Caravaca F.; Garcia M.C.; Esparrago J.F.; Casado E.S.

Renal function reserve in stable grafts and its relationship to renal morphologic parameters
pp. 2302-2303(2)
Authors: Fulladosa X.; Moreso F.; Narvaez J.A.; Condom E.; Torras J.; Alsina J.; Grinyo J.M.; Seron D.

Long-term outcome of focal segmental glomerulosclerosis after renal transplantation
pp. 2304-2305(2)
Authors: Holgado R.; Del Castillo D.; Mazuecos A.; Garca T.; Soriano S.; Perez R.; Aljama P.

Long-term results of combined kidney and liver transplantation in patients with nephropaty associated with liver disease
pp. 2306-2307(2)
Authors: Soriano S.; Del Castillo D.; Perez R.; Holgado R.; De La Mata M.; Solorzano G.; Aljama P.

Combined liver-kidney transplantation: our experience
pp. 2308-2308(1)
Authors: Torregrosa J.V.; Inigo P.; Navasa M.; Rimola A.; Grande L.; Oppenheimer F.

Differences between acute and chronic renal graft rejection on immunohistochemical staining of transforming growth factor Beta-1
pp. 2309-2310(2)
Authors: Inigo P.; Palacn A.; Campistol J.M.; Clesca P.H.; Vilardell J.; Sole M.; Oppenheimer F.

Calcitriol induces apoptosis of incubated lymphocyte T cells from patients with acute renal graft rejection
pp. 2311-2313(3)
Authors: Perez Calderon R.; Carracedo J.; Martin-Malo A.; Borrego M.J.; Ramirez R.; Lopez-Rubio F.; Rodriguez M.; Aljama P.

Borderline changes in kidney transplantation: evolution of treated cases versus nontreated
pp. 2314-2314(1)
Authors: Palomar R.; Ruiz J.C.; Val-Bernal F.; Escallada R.; Rodrigo E.; Cotorruelo J.; Heras M.; Arias M.

Oxidative stress in renal transplantation with uneventful postoperative course
pp. 2315-2316(2)
Authors: Romero F.; Herrera J.; Nava M.; Rodrguez-Iturbe B.

Cutaneous neoplasm and its relationship with factors due to renal transplant
pp. 2317-2318(2)
Authors: Bayes B.; Lauzurica R.; Fuente M.J.; Bonet J.; Ribera M.; Romero R.; Ferrandiz C.

Postrenal transplant erythrocytosis and insertion/deletion polymorphism of the angiotensin converting enzyme gene
pp. 2319-2320(2)
Authors: Torregrosa J.V.; Poch E.; Oriola J.; Campistol J.M.; Cofan F.; Inigo P.; Oppenheimer F.

Treatment with losartan in kidney transplant recipients with posttransplant erythrocytosis
pp. 2321-2321(1)
Authors: Inigo P.; Torregrosa J.V.; Campistol J.M.; Oppenheimer F.

Bone mineral density after renal transplantation: long-term follow-up
pp. 2322-2323(2)
Authors: Moreno A.; Torregrosa J.V.; Pons F.; Campistol J.M.; Martnez de Osaba M.J.; Oppenheimer F.

Kidney transplantation in patients with vasculitis and predominant renal involvement
pp. 2324-2325(2)
Authors: Bayes B.; Lauzurica R.; Serra A.; Bonet J.; Bonal J.; Teixido J.; Mirapeix E.; Romero R.

Fluvastatin in the treatment of hypercholesterolemia in renal transplantation
pp. 2326-2327(2)
Authors: Gomez G.; Alvarez M.L.; Errasti P.; Lavilla F.J.; Garca N.; Ballester B.; Garca I.; Purroy A.

Effect of atorvastatin of the treatment of hypercholesterolemia after renal transplantation
pp. 2328-2329(2)
Authors: Alvarez M.L.; Errasti P.; Gomez G.; Lavilla F.J.; Garca N.; Ballester B.; Garca I.; Purroy A.

Fatty acid composition in low-density lipoproteins from renal transplant recipients
pp. 2330-2332(3)
Authors: Cofan F.; Zambon D.; Rodriguez C.; Laguna J.C.; Vazquez M.; Casals E.; Torregrosa J.; Ros E.; Oppenheimer F.

Oxidation of low-density lipoproteins in renal transplant recipients
pp. 2333-2334(2)
Authors: Cofan F.; Zambon D.; Rodriguez C.; Laguna J.C.; Vazquez M.; Casals E.; Torregrosa J.; Ros E.; Oppenheimer F.

Acyclovir prophylaxis of cytomegalovirus disease in kidney transplant recipients
pp. 2335-2336(2)
Authors: Vila A.; Guirado L.L.; Balius A.; Daz M.; Baro E.; Olaya M.; Andrade M.; Agraz I.; Sola R.

Prophylaxis of cytomegalovirus disease with intravenous ganciclovir in renal transplantation
pp. 2337-2338(2)
Authors: Sancho A.; Gorriz J.L.; Crespo J.F.; Avila A.; Alcaraz M.J.; Garca Ramos J.L.; Pallardo L.M.

Prospective study of Epstein-Barr virus chronic infection in renal transplant recipients
pp. 2339-2340(2)
Authors: Lauzurica R.; Frias C.; Bayes B.; Hernandez A.; Bonet J.; Arnal J.; Romero R.; Ausina V.

Chickenpox in four adult renal transplant recipients
pp. 2341-2342(2)
Authors: Errasti P.; Alvarez M.L.; Gomez G.; Lavilla F.J.; Garcia N.; Ballester B.; Garca I.; Purroy A.

Infections in children following renal transplantation
pp. 2343-2343(1)
Authors: Garca Meseguer C.; Martnez M.J.; Alonso A.; Mur O.; Navarro M.

Effect of ET_A/ET_B receptor antagonist administration on iNOS gene expression in a rat renal transplantation model - Experimental preservation
pp. 2344-2345(2)
Authors: Herrero I.; Torras J.; Bover J.; Espinosa L.I.; Cruzado J.M.; Riera M.; Hueso M.; Lloberas N.; Alsina J.; Grinyo J.M.

Ischemic preconditioning improves postischemic acute renal failure
pp. 2346-2347(2)
Authors: Riera M.; Herrero I.; Torras J.; Cruzado J.M.; Fatjo M.; Lloberas N.; Alsina J.; Grinyo J.M.

Experimental kidney transplantation in pigs from non-heart-beating donors: evaluation of renal artery flow
pp. 2348-2349(2)
Authors: Alcoberro J.; Alcaraz A.; Alvarez-Vijande R.; Calatrava P.; Luque P.; Rodriguez A.; Aguilar A.; Gibanel R.; Llopis J.; Sole M.; Farre X.; Helena M.; Talbot-Wright R.

Experimental model of non-heart-beating donors: oxidative stress metabolism in kidney after cardiac arrest (30 minutes of warm ischemia) and reimplantation 24 hours later
pp. 2350-2351(2)
Authors: Monton S.; Herrera J.; Ferrer J.V.; Guerrero D.; Balen E.; Lera J.M.

Experimental study of the cellular energy charge in pig kidney transplants from non-heart-beating donors
pp. 2352-2353(2)
Authors: Luque P.; Alvarez-Vijande R.; Alcaraz A.; Aguilar A.; Alcoberro J.; Rodriguez A.; Gibanel R.; Calatrava P.; Helena M.; Llopis J.; Crisol I.; Sole M.; Farre X.; Talbot-Wright R.; Carretero P.

Renal transplantation in Catalonia, 1984-1997 - Miscellaneous
pp. 2354-2357(4)
Authors: Vela E.; Cleries M.

Model of a telematic network for communication between centers in a kidney transplant area
pp. 2358-2358(1)
Authors: Ruiz J.C.; Escallada R.; Cotorruelo J.G.; Zubimendi J.A.; Heras M.; Arias M.

Comparative study of antifibrinolytic drugs in orthotopic liver transplantation
pp. 2361-2362(2)
Authors: Dalmau A.; Sabate A.; Acosta F.; Garcia-Huete L.; Koo M.; Reche M.; Rafecas A.; Figueras J.; Jaurrieta E.

Influence of positive crossmatch in the outcome of liver transplantation
pp. 2363-2363(1)
Authors: Dagher L.; Chavez R.; Taylor C.; Smith S.T.; Alexander G.; Jamieson N.

Cardiovascular risk factors and late cardiovascular disease in liver transplantation
pp. 2364-2365(2)
Authors: Romero M.; Parera A.; Salcedo M.; Abeytua M.; Banares R.; de Diego A.; Santos L.; Clemente G.

Reversal of QT interval electrocardiographic alterations in cirrhotic patients undergoing liver transplantation
pp. 2366-2367(2)
Authors: Gonzalez M.G.; Hernandez-Madrid A.; Lopez-Sanroman A.; Candela A.; Nuno J.; Barcena R.

Is there a cirrhotic myocardiopathy in patients proposed for liver transplantation?
pp. 2368-2368(1)
Authors: Acosta F.; Sansano T.; Reche M.; Roques V.; Beltran R.; Rodriguez M.A.; Contreras R.F.; Robles R.; Bueno F.S.; Ramirez P.; Parrilla P.

Evaluation of cardiac function before and after liver transplantation
pp. 2369-2370(2)
Authors: Acosta F.; De La Morena G.; Villegas M.; Sansano T.; Reche M.; Beltran R.; Roques V.; Contreras R.F.; Robles R.; Bueno F.S.; Ramirez P.; Parrilla P.

Hemodynamic profile in cirrhotic patients undergoing liver retransplantation due to chronic rejection
pp. 2371-2371(1)
Authors: Acosta F.; Sansano T.; Contreras R.F.; Reche M.; Beltran R.; Roques V.; Rodriguez M.A.; Robles R.; Bueno F.S.; Ramirez P.; Parrilla P.

Cardiac evaluation of patients with familial amyloidotic polyneuropathy proposed for liver transplantation
pp. 2372-2372(1)
Authors: Acosta F.; De La Morena G.; Villegas M.; Sansano T.; Reche M.; Beltran R.; Roques V.; Contreras R.F.; Robles R.; Bueno F.S.; Ramirez P.; Parrilla P.

Phenylephrine treatment of the postreperfusion syndrome in liver transplantation
pp. 2373-2374(2)
Authors: Acosta F.; Sansano T.; Contreras R.F.; Reche M.; Roques V.; Beltran R.; Rodriguez M.A.; Robles R.; Bueno F.S.; Ramirez P.; Parrilla P.

Hemodynamic consequences of oxidative stress following reperfusion during liver transplantation
pp. 2375-2376(2)
Authors: Acosta F.; Serrano E.; Diaz J.; Carbonell L.; Sansano T.; Beltran R.; Roques V.; Contreras R.F.; Robles R.; Bueno F.S.; Ramirez P.; Parrilla P.

Atropine prophylaxis of the postreperfusion syndrome in liver transplantation
pp. 2377-2377(1)
Authors: Acosta F.; Sansano T.; Contreras R.F.; Reche M.; Beltran R.; Roques V.; Rodriguez M.A.; Robles R.; Bueno F.S.; Ramirez P.; Parrilla P.

Plasma redox imbalance during reperfusion and early posttransplantation cholestasis parameters in human liver transplantation
pp. 2378-2379(2)
Authors: Serrano E.; Daz J.; Acosta F.; Parrilla P.; Carbonell L.F.

Influence of surgical technique on postreperfusion syndrome during liver transplantation
pp. 2380-2381(2)
Authors: Acosta F.; Rodriguez M.A.; Sansano T.; Contreras R.F.; Reche M.; Roques V.; Beltran R.; Robles R.; Bueno F.S.; Ramirez P.; Parrilla P.

Changes in serum potassium during reperfusion in liver transplantation
pp. 2382-2383(2)
Authors: Acosta F.; Sansano T.; Contreras R.F.; Reche M.; Beltran R.; Roques V.; Rodriguez M.A.; Robles R.; Bueno F.S.; Ramirez P.; Parrilla P.

Effect of reperfusion on right ventriculoarterial coupling in liver transplantation
pp. 2384-2385(2)
Authors: Acosta F.; Reche M.; Sansano T.; Contreras R.F.; Beltran R.; Roques V.; Rodriguez M.A.; Robles R.; Bueno F.S.; Ramirez P.; Parrilla P.

Surgery for esophageal varix bleeding in cirrhotic patients during the era of liver transplants
pp. 2386-2387(2)
Authors: Robles R.; Parrilla P.; Hernandez Q.; Lopez J.; Ramrez P.; Bueno F.S.; Acosta F.; Rodriguez J.M.; Lujan J.A.

Analysis of the complications of the piggy-back technique in 1112 liver transplants - Surgical technique
pp. 2388-2389(2)
Authors: Parrilla P.; Sanchez-Bueno F.; Figueras J.; Jaurrieta E.; Mir J.; Margarit C.; Lazaro J.; Herrera L.; Gomez-Fleitas M.; Varo E.; Vicente E.; Robles R.; Ramirez P.

Complications related to hepatic venous outflow in piggy-back liver transplantation: two- versus three-suprahepatic-vein anastomosis
pp. 2390-2391(2)
Authors: Robles R.; Parrilla P.; Acosta F.; Bueno F.S.; Ramirez P.; Lopez J.; Lujan J.A.; Rodriguez J.M.; Fernandez J.A.; Pico F.

Management of the biliary complications associated with liver transplantation: 13 years of experience
pp. 2392-2393(2)
Authors: Turrion V.S.; Alvira L.G.; Jimenez M.; Lucena J.L.; Nuno J.; Pereira F.; Vicente E.; Ardaiz J.

Need for venovenous bypass in patients with familial amyloidotic polyneuropathy treated with liver transplantation
pp. 2394-2395(2)
Authors: Acosta F.; Sansano T.; Rodriguez M.A.; Contreras R.F.; Reche M.; Beltran R.; Roques V.; Robles R.; Bueno F.S.; Ramirez P.; Parrilla P.

Routine use of the T tube in the biliary reconstruction of liver transplantation: is it worthwhile?
pp. 2396-2397(2)
Authors: Grande L.; Perez-Castilla A.; Matus D.; Rodriguez-Montalvo C.; Rimola A.; Navasa M.; Garca-Valdecasas J.C.; Visa J.

Use of perihepatic packing in the management of intraoperative hemorrhage in liver transplantation
pp. 2398-2399(2)
Authors: Rodriguez-Montalvo C.; Grande L.; Rimola A.; Mas A.; Salmeron J.M.; Navasa M.; Garca-Valdecasas J.C.; Matus D.; Visa J.

Portosuprahepatic shunt as an alternative to portocaval shunt in anhepatic patients waiting for an orthotopic liver transplant
pp. 2400-2401(2)
Authors: Robles R.; Parrilla P.; Acosta F.; Bueno F.S.; Ramirez P.; Lujan J.A.; Rodriguez J.M.; Lopez J.; Fernandez J.A.

Need for inotropic and/or vasopressor drugs during liver transplantation
pp. 2402-2403(2)
Authors: Acosta F.; Rodriguez M.A.; Sansano T.; Contreras R.F.; Reche M.; Roques V.; Beltran R.; Robles R.; Bueno F.S.; Ramirez P.; Parrilla P.

Intravenous anesthesia with propofol for liver transplantation in pigs
pp. 2404-2404(1)
Authors: Cruz J.I.; Burzaco O.; Campoy L.; Ruiz J.; Escartin A.; Garca-Gil F.A.

Diagnostic and therapeutic management of hepatic artery thrombosis after liver transplantation
pp. 2405-2405(1)
Authors: Torras J.; Llado L.; Figueras J.; Ramos E.; Lama C.; Fabregat J.; Rafecas A.; Escalante E.; Dominguez J.; Sancho C.; Jaurrieta E.

Biliary tract complications after liver transplantation: type, management, and outcome
pp. 2406-2406(1)
Authors: Torras J.; Llado L.; Figueras J.; Ramos E.; Lama C.; Fabregat J.; Rafecas A.; Escalante E.; Dominguez J.; Sancho C.; Jaurrieta E.

Incidence and management of biliary tract complications following 300 consecutive orthotopic liver transplants
pp. 2407-2408(2)
Authors: Hernandez Q.; Ramirez P.; Munitiz V.; Pinero A.; Robles R.; Sanchez-Bueno F.; Rodriguez J.M.; Lujan J.; Acosta F.; Miras M.; Pons J.A.; Parrilla P.

Vascular complications in a series of 300 orthotopic liver transplants
pp. 2409-2410(2)
Authors: Sanchez-Bueno F.; Hernandez Q.; Ramrez P.; Robles R.; Acosta F.; Rodrguez J.M.; Parrilla P.

Biliary complications in liver transplantation for cystic fibrosis
pp. 2411-2412(2)
Authors: Chavez-Cartaya R.; Drage M.; Jamieson N.V.; Friend P.; Noble-Jamieson G.; Levy R.; Barnes N.; Calne R.

Hemodynamic consequences of portal and lateral clamping of the inferior vena cava during liver transplantation
pp. 2413-2414(2)
Authors: Acosta F.; Sansano T.; Robles R.; Contreras R.F.; Reche M.; Beltran R.; Roques V.; Rodriguez M.A.; Bueno F.S.; Ramirez P.; Parrilla P.

Liver transplantation in cirrhotic patients with thrombosis of the portal vein
pp. 2415-2415(1)
Authors: Robles R.; Parrilla P.; Hernandez Q.; Bueno F.S.; Ramrez P.; Lopez J.; Acosta F.; Fernandez J.A.

Risk factors for late hepatic artery thrombosis in adult liver transplantation
pp. 2416-2417(2)
Authors: Hidalgo E.; Cantarell C.; Charco R.; Murio E.; Lazaro J.L.; Bilbao I.; Margarit C.

Peripheral blood lymphocyte phenotype can predict rejection episodes after orthotopic liver transplantation
pp. 2418-2420(3)
Authors: Perdigoto R.; Paiva A.; Freitas A.; Breda Coimbra H.; Mota O.; Ferrao J.; Tome L.; Furtado E.; Cipriano M.A.; Geraldes B.; Oliveira F.J.; Furtado A.L.

Comparison of cyclosporine immunoassays (Axsym and RIA) for assessing pharmacokinetic parameters in liver transplant patients
pp. 2421-2422(2)
Authors: Sabate I.; Liron F.J.; Gonzalez Alba J.M.; Ginard M.; Virgili J.; Baro S.; Figueras J.; Gonzalez Segura C.; Jaurrieta E.

Comparison of postliver transplantation electrocardiographic alterations between cyclosporine- and tacrolimus-treated patients
pp. 2423-2424(2)
Authors: Gonzalez M.G.; Hernandez-Madrid A.; Sanroman A.L.; Monge G.; De Vicente E.; Barcena R.

Usefulness of the switch to tacrolimus in liver transplantation
pp. 2425-2426(2)
Authors: Gonzalez-Pinto I.; Alonso O.; Loinaz C.; Gomez R.; Rodrguez-Canete A.; Rodrguez F.; Perez-Saborido B.; Paseiro G.; Moreno-Gonzalez E.

Immunosuppression in liver transplantation: a european survey
pp. 2427-2428(2)
Authors: Barcena R.; Lopez-San Roman A.; Garca M.; Ruiz Del Arbol L.; De Vicente E.; Candela A.

Hepatotrophic effect of cyclosporine and FK 506 is not mimicked by Rapamycin
pp. 2429-2429(1)
Authors: Chavez R.; Jamieson N.; Takamori S.; Nivatvongs S.; Pino G.; Metcalfe A.; Watson C.; Romero D.; Metcalfe S.

Mycophenolate mofetil overlap in liver transplant recipients with chronic cyclosporine nephrotoxicity
pp. 2430-2430(1)
Authors: Torras J.; Figueras J.; Lama C.; Fabregat J.; Ramos E.; Rafecas A.; Gil-Vernet S.; Pares D.; Busquets J.; Jaurrieta E.

Effect of treatment with tranexamic acid on complement activation and ischemia reperfusion in liver transplantation in pigs - Ischemia-reperfusion injury; postoperative liver function
pp. 2431-2432(2)
Authors: Nwose P.E.; Regueira F.M.; Sierra A.; Diez-Caballero A.; Hernandez J.L.; Pardo F.; Cienfuegos J.A.

Usefulness of celsior in graft preservation of livers obtained from non heart beating donors in experimental (pigs) liver transplantation: comparative study with University of Wisconsin solution
pp. 2433-2434(2)
Authors: Valero R.; Almenara R.; Garca-Valdecasas J.C.; Beltran J.; Net M.; Capdevila L.; Lopez Boado M.A.; Gonzalez F.X.; Taura P.; Visa J.; Manyalich M.

Value of alpha-glutathione sulfotransferase in the assessment of hepatic injury after experimental long-term preservation
pp. 2435-2436(2)
Authors: Cascales P.; Fernandez-Cornejo V.J.; Sanchez-del Campo F.; de Torre M.; Sanchez Eixeres M.R.; Soriano N.; Gonzalez F.

Evaluation of celsior solution in experimental liver preservation using ex situ isolated rat liver perfusion
pp. 2437-2438(2)
Authors: Cascales P.; Fernandez-Cornejo V.; Sanchez-Del Campo F.; de Torre M.; Sanchez-Eixeres M.R.; Soriano N.; Gonzalez F.

Free radical scavengers to prevent reperfusion injury following warm liver ischemia
pp. 2439-2440(2)
Authors: Chavez-Cartaya R.; Jamieson N.V.; Ramirez P.; Marin J.; Pino-Chavez G.

Evaluation of beta-oxidation parameters and mitochondrial redox state as early markers of hepatic function in hepatic transplantation
pp. 2441-2442(2)
Authors: Igea J.; Nuno J.; Lopez-Hervas P.; Quijano Y.; Honrubia A.; Candela A.; Monge G.; Moreno A.; Barcena R.; San Roman A.; Garca M.; Pallares E.; de Vicente E.

Evaluation of glycolytic parameters and cytoplasmic redox status as markers of hepatic function in liver transplantation
pp. 2443-2444(2)
Authors: Igea J.; Nuno J.; Lopez-Hervas P.; Quijano Y.; Honrubia A.; Candela A.; Monge G.; Moreno A.; Barcena R.; San Roman A.; Garca M.; de Vicente E.

Ammonia levels as early markers of good graft revascularization in hepatic transplantation - Biology and Pathobiology
pp. 2445-2446(2)
Authors: Igea J.; Nuno J.; Lopez-Hervas P.; Quijano Y.; Honrubia A.; Candela A.; Monge G.; Moreno A.; Barcena R.; San Roman A.; Garca M.; de Vicente E.

Indocyanine green clearance as a marker of graft function in liver transplantation
pp. 2447-2448(2)
Authors: Igea J.; Nuno J.; Lopez-Hervas P.; Quijano Y.; Honrubia A.; Candela A.; Monge G.; Moreno A.; Barcena R.; San Roman A.; Garca M.; de Vicente E.

Orthotopic liver transplantation in patients over 60 years of age
pp. 2449-2452(4)
Authors: Jimenez C.; Gandara N.; Chamorro A.G.; Romano D.R.; Rodrguez F.; Loinaz C.; Palomo J.C.; Hernandez D.; Garca I.; Moreno E.

Indications and results of liver transplants in Wilson's disease - Wilson's disease
pp. 2453-2454(2)
Authors: Robles R.; Parrilla P.; Sicilia J.; Ramrez P.; Bueno F.S.; Rodrguez J.M.; Lujan J.A.; Fernandez J.A.; Lopez J.

Surgical treatment of hepatocellular carcinoma in cirrhotic and noncirrhotic patients
pp. 2455-2456(2)
Authors: Figueras J.; Ramos E.; Ibanez L.; Rafecas A.; Fabregat J.; Torras J.; Lama C.; Ruiz D.; Moreno G.; Arteche N.; Jaurrieta E.

Lamivudine therapy of hepatitis B virus-related liver disease: cirrhosis, posttransplantation recurrence, and de novo infection
pp. 2457-2458(2)
Authors: Barcena R.; Domnguez-Antonaya M.; Lopez-Sanroman A.; Martnez-Turnes A.; Urman J.; del Campo S.; Moreno N.

Response to hepatitis B virus vaccine in patients transplanted for HBV-related liver disease under specific gammaglobulin prophylaxis
pp. 2459-2460(2)
Authors: Barcena R.; Fernandez-Braso M.; Urman J.; Lopez-San Roman A.; del Campo S.; Moreno N.; Lopez P.; Garcia M.; Plaza M.P.; Garcia Plaza A.

Influence of antiviral therapy on the natural history of hepatitis B virus recurrence after liver transplantation: retrospective study of 14 cases
pp. 2461-2463(3)
Authors: Vizuete S.G.; Encinas J.L.; Prados E.; Haro J.; Cuervas-Mons V.

Transmission of hepatitis B virus by transplantation of livers from donors positive for antibody to hepatitis B core antigen
pp. 2464-2465(2)
Authors: Castells L.; Vargas V.; Rodrguez-Fras F.; Allende H.; Jard R.; Margarit C.; Esteban R.; Guardia J.

HLA class I expression on peripheral blood lymphocytes and hepatocytes after liver transplantation
pp. 2466-2468(3)
Authors: Minguela A.; Bermejo J.; Pons J.A.; Miras M.; Torio A.; Marin L.; Garca-Alonso A.M.; Ramrez P.; Alvarez-Lopez M.R.

Evaluation of delta bilirubin in the follow-up of hepatic transplantation
pp. 2469-2469(1)
Authors: Igea J.; Nuno J.; Lopez-Hervas P.; Quijano Y.; Honrubia A.; Candela A.; Monge G.; Moreno A.; Barcena R.; San Roman A.; Garca M.; de Vicente E.

Labor status of 137 patients with liver transplantation
pp. 2470-2471(2)
Authors: Loinaz C.; Clemares M.; Marques E.; Paseiro G.; Gomez R.; Gonzalez-Pinto I.; Jimenez C.; Garca I.; Moreno E.

Recurrence of alcoholism and quality of life in patients with alcoholic cirrhosis following liver transplantation
pp. 2472-2474(3)
Authors: Mejas D.; Ramrez P.; Ros A.; Munitiz V.; Hernandez Q.; Bueno F.; Robles R.; Torregrosa N.; Miras M.; Ortiz M.; Barcia D.; Parrilla P.

Clinical features of 32 patients after 8 years of a liver transplant
pp. 2475-2476(2)
Authors: Loinaz C.; Marques E.; Gomez R.; Jimenez C.; Gonzalez-Pinto I.; Citores M.A.; Musella M.; Garcia I.; Moreno E.

Effect of HLA matching on liver graft survival - Functional and Medical Implications
pp. 2477-2479(3)
Authors: Muro M.; Marn L.; Toro A.; Moya-Quiles M.R.; Ontanon J.; Minguela A.; Alemany J.M.; Sanchez-Bueno F.; Garca-Alonso A.M.; Alvarez-Lopez M.R.

Liver donors: is age a risk factor?
pp. 2480-2481(2)
Authors: Busquets J.; Figueras J.; Torras J.; Fabregat J.; Rafecas A.; Ramos E.; Lama C.; Jaurrieta E.

Effect of donor age on graft outcome after liver transplantation
pp. 2482-2483(2)
Authors: Grande L.; Matus D.; Manyalic M.; Cabrer C.; Rodriguez-Montalvo C.; Rimola A.; Navasa M.; Garcia-Valdecasas J.C.; Visa J.

Liver transplantation in Catalonia from 1984 to 1997
pp. 2484-2484(1)
Authors: Cleries M.; Vela E.; Bosch A.; Charco R.; Grande L.l.; Lama C.

Influence of renal function upon the outcome of liver retransplanted patients: results of a multivariate analysis
pp. 2485-2486(2)
Authors: Pares D.; Figueras J.; Rafecas A.; Fabregat J.; Torras J.; Ramos E.; Lama C.; Guardiola J.; Jaurrieta E.

Comparative study of survival after liver transplantation in cirrhotic patients with and without hepatocellular carcinoma
pp. 2487-2488(2)
Authors: Figueras J.; Ramos E.; Ibanez L.; Rafecas A.; Fabregat J.; Torras J.; Lama C.; Ruiz D.; Moreno G.; Arteche N.; Jaurrieta E.

Long-term results of liver transplantation in four siblings from the same family with familial amyloidotic polyneuropathy type I TTR ALA-71
pp. 2489-2490(2)
Authors: Ramrez P.; De Mingo P.; Andreu F.; Munar M.; Hernandez Q.; Munitiz V.; Rios A.; Pons J.A.; Miras M.; Robles R.; Sanchez-Bueno F.; Parrilla P.

Orthotopic liver transplantation in alcoholic liver cirrhosis
pp. 2491-2493(3)
Authors: Romano D.R.; Jimenez C.; Rodrguez F.; Loinaz C.; Colina F.; Urena M.A.; Garca I.; Moreno E.

Liver transplantation in the management of Klastkin's tumor
pp. 2494-2495(2)
Authors: Robles R.; Parrilla P.; Bueno F.S.; Ramrez P.; Lujan J.A.; Rodrguez J.M.; Acosta F.; Lopez J.; Hernandez Q.

Recipients and donors: a life-paradox
pp. 2496-2497(2)
Authors: Gonzalez Segura C.; Tormos P.; Torras J.; Pascual M.; Figueras J.; Manito N.; Sabate I.; Pedro M.V.; Ramos R.

Reduction aortoplasty: readaptation technique in great vessel mismatches in heart transplantation
pp. 2501-2502(2)
Authors: Miralles A.; Espinoza C.; Rodriguez R.; Flajsig I.; Saura E.; Calbet J.M.; Granados J.; Benito M.; Castells E.

Reversibility of pulmonary hypertension in patients evaluated for orthotopic heart transplantation: importance in the postoperative morbidity and mortality
pp. 2503-2504(2)
Authors: Espinoza C.; Manito N.; Roca J.; Castells E.; Mauri J.; Ribas M.; Claret G.

Usefulness of nitric oxide inhalation for management of right ventricular failure after heart transplantation in patients with pretransplant pulmonary hypertension
pp. 2505-2506(2)
Authors: Paniagua M.J.; Crespo-Leiro M.G.; Rodrguez J.A.; Fojon S.; Pastor J.; Castro M.J.; Hermida L.F.; Cuenca J.J.; Juffe-Stein A.; Castro-Beiras A.

Pretransplant risk factors of early mortality after orthotopic heart transplantation - Conferencia Consenso Nacional 1996
pp. 2507-2508(2)
Authors: Espinoza C.; Manito N.; Castells E.; Roca J.; Rodriguez R.; Octavio de Toledo M.C.; Calbet J.M.; Fontanillas C.; Saura E.; Miralles A.; Granados J.; Benito M.; Mauri F.; Ramon J.M.; Obi C.; Quiles C.; Claret G.

Perioperative mortality risk factors after orthotopic heart transplantation - Conferencia Consenso Nacional 1996
pp. 2509-2510(2)
Authors: Espinoza C.; Manito N.; Castells E.; Rodriguez R.; Octavio de Toledo M.C.; Calbet J.M.; Fontanillas C.; Saura E.; Miralles A.; Granados J.; Benito M.; Roca J.; Mauri F.; Ramon J.M.; Obi C.; Quiles C.; Claret G.

Surgical extracardiac thoracic complications in heart transplantation
pp. 2511-2512(2)
Authors: Castells E.; Espinoza C.; Calbet J.M.; Octavio de Toledo M.C.; Saura E.; Benito M.; Granados J.; Manito N.; Miralles A.; Roca J.; Rodriguez R.; Rullan C.; Esplugas E.

Combined heart and kidney transplantation
pp. 2513-2514(2)
Authors: Crespo-Leiro M.G.; Rodriguez J.A.; Paniagua M.J.; Hermida L.F.; Cuenca J.J.; Juffe-Stein A.; Gomez-Veiga F.; Alonso A.; Vilela D.; Castro-Beiras A.

Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy
pp. 2515-2516(2)
Authors: Sanchez V.; Delgado J.F.; Blasco T.; Dalmau R.; Morales J.M.; Escribano P.; Tello R.; Hernandez J.; Velazquez T.; Sotelo T.; Gomez-Sanchez M.A.; Saenz de la Calzada C.

Induction of immunosuppression with OKT3 following heart transplantation: kidney function as a criterion for control of protocol duration
pp. 2517-2518(2)
Authors: Rodrguez J.A.; Crespo-Leiro M.G.; Paniagua M.J.; Muniz J.; Hermida L.F.; Fojon S.; Cuenca J.J.; Juffe-Stein A.; Castro-Beiras A.

Incidence of side effects of immunosuppressants commonly used in heart transplantation
pp. 2519-2521(3)
Authors: Almenar L.; Rueda J.; Osa A.; Arnau M.A.; Martinez-Dolz L.; Palencia M.

Rhabdomyolysis in heart transplant patients on HMG-CoA reductase inhibitors and cyclosporine
pp. 2522-2523(2)
Authors: Rodrguez J.A.; Crespo-Leiro M.G.; Paniagua M.J.; Cuenca J.J.; Hermida L.F.; Juffe A.; Castro-Beiras A.

Study of early corticosteroid withdrawal in cardiac transplantation
pp. 2524-2525(2)
Authors: Delgado D.; Cohen Arazi H.; Sellanes M.; Caceres M.; Cardenas C.; Morales C.; Bortman G.; Nojek C.

Usefulness of quantitative Cytomegalovirus antigenemia determinations in heart transplantation
pp. 2526-2527(2)
Authors: Manito N.; Perez J.L.; Roca J.; Castells E.; Niubo J.; Garcia A.; Ribas M.; Saura E.; Ruf G.; Gomez-Hospital J.A.; Espinoza C.; Esplugas E.

Preemptive and prophylactic ganciclovir therapy for CMV infection in heart transplant patients
pp. 2528-2529(2)
Authors: Paniagua M.J.; Crespo-Leiro M.G.; Rodriguez J.A.; Fojon S.; Zuniga M.C.; Canizares A.; Rey R.; Cuenca J.J.; Juffe A.; Castro-Beiras A.

Prevention of symptomatic infection by herpesvirus in patients after heart transplantation
pp. 2530-2530(1)
Authors: Cohen Arazi H.; Delgado D.; Carosella V.; Sellanes M.; Caceres M.; Cardenas C.; Lorenzo L.; Bortman G.; Nojek C.

A study of the experience of Spanish Heart Transplant Groups
pp. 2531-2533(3)
Authors: Almenar L.; Arizon J.M.

Heart transplantation: our experience in 450 cases
pp. 2534-2534(1)
Authors: Roda J.R.; Castedo E.; Tellez J.C.; Burgos R.; Serrano-Fiz S.; Montero C.G.; Tellez G.; Segovia J.; Pulpon L.A.; Ugarte J.

Heart transplantation in Catalonia, 1984-1997
pp. 2535-2536(2)
Authors: Salas T.; Cleries M.; Vela E.; Ballester M.; Manito N.

Morbidity and mortality among heart transplant patients older and younger than 65 years
pp. 2537-2538(2)
Authors: Crespo-Leiro M.G.; Paniagua M.J.; Rodriguez J.A.; Hermida L.F.; Fojon S.; Vazquez N.; Muniz J.; Cuenca J.J.; Juffe-Stein A.; Castro-Beiras A.

Midterm results of percutaneous transluminal coronary angioplasty in graft coronary artery disease in cardiac transplant patients
pp. 2539-2541(3)
Authors: Marelli M.; Rabago G.; Calabuig J.; Martnez Caro D.; Coma-Canella I.; Martn Trenor A.

Coronary artery disease transmitted by donors older than 40 years: prevalence and prognosis
pp. 2542-2543(2)
Authors: Crespo-Leiro M.G.; Rodriguez J.A.; Portela F.; Paniagua M.J.; Muniz J.; Hermida L.F.; Vazquez N.; Cuenca J.J.; Juffe-Stein A.; Castro-Beiras A.

Utility of acoustic densitometry in graft rejection diagnosis in heart transplantation
pp. 2544-2544(1)
Authors: Almenar L.; Osa A.; Miro V.; Arnau M.A.; Dicenta F.; Dolz L.M.; Rueda J.; Palencia M.

Usefulness of pulsed Doppler tissue imaging for noninvasive detection of cardiac rejection after heart transplantation
pp. 2545-2547(3)
Authors: Fabregas R.I.; Crespo-Leiro M.G.; Muniz J.; Regueiro M.; Rodriguez J.A.; Alvarez N.; Peteiro J.; Paniagua M.J.; Vazquez J.M.; Cuenca J.J.; Castro-Beiras A.

Right bundle branch block as a prognostic factor in heart transplantation - Electrophysiology, Diagnosis and Management
pp. 2548-2549(2)
Authors: Almenar L.; Osa A.; Arnau M.A.; Dolz L.M.; Rueda J.; Palencia M.

Ischemic injury in posttransplant endomyocardial biopsies: immunohistochemical study of fibronectin
pp. 2550-2551(2)
Authors: Panizo A.; Pardo F.J.; Lozano M.D.; de Alava E.; Sola I.; Idoate M.A.

Levels of Lipoprotein(a) in cardiac transplant recipients
pp. 2552-2553(2)
Authors: Cristobal C.; Pulpon L.A.; Segovia J.; Gallego J.C.; Toquero J.

Rehospitalization needs in a cardiac transplantation unit
pp. 2554-2554(1)
Authors: Cristobal C.; Pulpon L.A.; Nunez A.; Segovia J.; Gallego Page J.C.

Analysis of quality of life before and after heart transplantation
pp. 2555-2555(1)
Authors: Bortman G.; Delgado D.; Cohen Arazi H.; Martin J.; Valente S.; Vazquez F.; Santini M.; Nojek C.

Influence of cold ischemia time on oxidative stress after experimental pancreas transplantation
pp. 2559-2559(1)
Authors: Zazpe C.; Balen E.M.; Ferrer J.V.; Saez M.J.; Guerrero D.; Herrera J.; Lera J.M.

Beta cell mass after transplantation of cryopreserved islets
pp. 2560-2560(1)
Authors: Nacher V.; Perez-Maraver M.; Jara R.; Soler J.; Montanya E.

Preserved beta cell function with insulin treatment in islet transplantation: effect on insulin gene expression
pp. 2561-2561(1)
Authors: Raurell M.; Merino J.F.; Nacher V.; Biarnes M.; Soler J.; Montanya E.

Small intestine transplantation from cadaver donors: procurement procedure
pp. 2565-2566(2)
Authors: Chavez-Cartaya R.; Jamieson N.V.; Friend P.J.; Middleton S.; Calne R.Y.

Orthotopic small bowel transplantation in pigs without steroids
pp. 2567-2568(2)
Authors: Escartn A.; Garca-Gil F.A.; Cruz J.I.; Burzaco O.; Ruiz J.; Gonzalvo E.; Marcuello B.

Orthotopic small bowel transplantation with exchange of grafts between two pigs: surgical technique
pp. 2569-2569(1)
Authors: Escartn A.; Garca-Gil F.A.; Cruz J.I.; Ruiz J.; Burzaco O.; Ela M.; Lagunas E.

Prevention by somatostatine and N-acetylcisteine of multiorgan failure mediated by oxidative stress after intestinal ischemia
pp. 2570-2571(2)
Authors: Ferrer J.V.; Ariceta J.; Guerrero D.; Balen E.; Herrera J.; Lera J.M.

Metabolism of the intestine with intermediate ischemia after intestinal ischemia-reperfusion injury: therapeutic effects of somatostatin
pp. 2572-2572(1)
Authors: Ariceta J.; Ferrer J.V.; Guerrero D.; Tellechea E.; Balen E.; Lera J.M.

Role of nitric oxide in preconditioning for intestinal transplantation
pp. 2573-2573(1)
Authors: de Oca J.; Hotter G.; Sola A.; Gonzalez R.; Rafecas A.; Rosello J.; Jaurrieta E.

Hemopoietic progenitor cell transplantation in Catalonia, 1988-1997
pp. 2577-2578(2)
Authors: Amado M.L.; Barba G.; Cleries M.

Discrepancies between serology- and sequence-based typing of HLA class I alleles among unrelated donor/recipient pairs
pp. 2579-2580(2)
Authors: Gimferrer I.; Arias M.T.; Suarez B.; Martorell J.; Vives J.; Lozano F.

Immune reconstitution after in utero bone marrow transplantation in a fetus with severe combined immunodeficiency with natural killer cells
pp. 2581-2581(1)
Authors: Gil J.; Porta F.; Bartolome J.; Lafranchi A.; Verardi R.; Notarangelo L.D.; Carlo-Stella C.; Rodrguez R.; Rodrguez J.J.; Gurbindo D.; Cela E.; Zucca A.; Fernandez-Cruz E.; Ugazio A.G.

Immune recovery after bone marrow and peripheral blood stem cells transplantation
pp. 2582-2584(3)
Authors: Marin G.H.; Mendez M.C.; Menna M.E.; Malacalza J.; Bergna M.I.; Klein G.; Italiano C.; Perez M.; Gil M.A.; Gardenal L.; Mansilla E.; Orlando S.; Saba S.; Canepa C.; Piccinelli G.

Evolution of the organ donor profile in Catalonia
pp. 2587-2588(2)
Authors: Garca Aparicio L.; Viedma M.A.; Lloveras J.; Aguayo M.T.; Vicente R.; Grinyo J.M.; Constante C.

Donor age and cause of brain death influence the number of organs retrieved and grafted
pp. 2589-2590(2)
Authors: Caballero F.; Lopez-Navidad A.; Leal J.; Garca-Sousa S.; Domingo P.

Short and long-term success of organs transplanted from donors dying of acute methanol intoxication
pp. 2591-2592(2)
Authors: Caballero F.; Cabrer C.; Gonzalez-Segura C.; Manyalich M.; Lopez-Navidad A.

Very old patients with spontaneous cerebral hemorrhage are an important group of potential organ donors
pp. 2593-2594(2)
Authors: Andres A.; Sanchez Casado M.; Cebrian P.; Vereda M.; Vazquez S.; Morales E.; Ramos A.; Escudero L.; Montejo J.C.; Montero A.; Alted E.

High-risk spontaneous cerebral hematomas leading to brain death: early detection of potential organ donors
pp. 2595-2596(2)
Authors: Dominguez-Roldan J.M.; Barrera-Chacon J.M.; Martin-Bermudez R.; Santamaria-Milsut J.L.; Flores-Cordero J.M.; Jimenez Gonzalez P.

Changes in the intracranial pulse pressure waveform associated with brain death
pp. 2597-2598(2)
Authors: Dominguez-Roldan J.M.; Barrera-Chacon J.M.; Martin-Bermudez R.; Murillo-Cabezas F.; Garcia-Alfaro C.; Rincon-Ferrari M.D.

Clinical factors influencing the increment of blood carbon dioxide during the apnea test for the diagnosis of brain death
pp. 2599-2600(2)
Authors: Dominguez-Roldan J.M.; Barrera-Chacon J.M.; Murillo-Cabezas F.; Santamaria-Mifsut J.L.; Rivera-Fernandez V.

The cultural level of cadaveric potential organ donor relatives determines the rate of consent for donation
pp. 2601-2601(1)
Authors: Caballero F.; Lopez-Navidad A.; Leal J.; Garca-Sousa S.; Soriano J.A.; Domingo P.

Distribution of organ donors on a weekly and annual basis according to cause of death
pp. 2602-2603(2)
Authors: Leal J.; Caballero F.; Garca-Sousa S.; Domingo P.; Lopez-Navidad A.

Psychopathology of bereavement in the families of cadaveric organ donors
pp. 2604-2605(2)
Authors: Soriano-Pacheco J.A.; Lopez-Navidad A.; Caballero F.; Leal J.; Garca-Sousa S.; Linares J.L.

Importance of the transplant coordinator in tissue donor detection
pp. 2606-2606(1)
Authors: Navarro A.; Cabrer C.; De Cabo F.M.; Paredes D.; Valero R.; Manyalich M.

Potential cornea donors in a general hospital
pp. 2607-2608(2)
Authors: Garca-Sousa S.; Lopez-Navidad A.; Caballero F.; Leal J.; Viedma M.A.

Importance of donor selection and corneal viability
pp. 2609-2609(1)
Authors: Navarro A.; Cabrer C.; De Cabo F.M.; Paredes D.; Escalada J.; Costa J.; Manyalich M.

Transplant procurement management: a training tool to increase donation - The Solutions
pp. 2610-2611(2)
Authors: Paredes D.; Valero R.; Navarro A.; Miranda B.; Viedma M.; Cabrer C.; Manyalich M.

Survey of secondary education teachers in Catalonia on donation and transplants
pp. 2612-2613(2)
Authors: Lopez-Navidad A.; Vilardell J.; Aguayo M.T.; Albadalejo C.; Cabrer C.; Cuello J.; Echebarra I.; Martnez-Castelao A.; Tarres M.; Vicente R.; Lloveras J.; Viedma M.A.

Optimizing organ donation in Portugal
pp. 2614-2615(2)
Authors: Teixeira J.; Cruz J.; Fiuza C.; Araujo R.; Braga A.

Abdominal laparoscopy in follow-up of heterotopic pig heart to baboon xenotransplantation
pp. 2619-2619(1)
Authors: Crespo F.M.; Centeno A.; Lopez E.; Juffe A.; Manez R.

Alterations of lipoprotein metabolism in a concordant model of liver xenotransplantation
pp. 2620-2621(2)
Authors: Mollev D.G.; Ribas Y.; Jaurrieta E.; Gomez N.; de Oca J.; Fiol C.; Figueras J.

Evolution of blood coagulation factors and hemotherapeutic support in three pig-to-baboon orthotopic liver xenotransplants
pp. 2622-2624(3)
Authors: Majado M.J.; Ramrez P.; Minguela A.; Hernandez Q.; Gonzalez C.; Loba M.; Muntiz V.; Rubio A.; Chavez R.; Acosta F.; Garca C.; Pino G.; Robles R.; Bueno F.S.; Asensi H.; Candel R.; Parrilla P.

Hemodynamic alterations during liver xenotransplantation from pig to baboon
pp. 2625-2626(2)
Authors: Ramirez P.; Chavez R.; Majado M.; Munitiz V.; Hernandez Q.; Loba M.; Acosta F.; Garcia C.; Asensi H.; Pino G.; Minguela A.; Munoz A.; Yelamos J.; Navarro F.; Bueno F.; Robles R.; Calne R.Y.; Parrilla P.

Surgical procedure for specific pathogen free piglet production by modified terminal hysterectomy
pp. 2627-2629(3)
Authors: Munoz A.; Ramis G.; Pallares F.J.; Martnez J.S.; Oliva J.E.; Martnez M.; Munitiz V.; Yelamos J.; Ramirez P.; Parrilla P.

Human T-Cell response to L14 pig cell line transfected with human ligands CD80 and CD86
pp. 2630-2630(1)
Authors: Millan O.; Rojo I.; Juan M.; Vilardell C.; Yague J.; Vives J.; Martorell J.

Serum levels of xenoantibodies in different groups of patients awaiting transplantation
pp. 2631-2632(2)
Authors: Ramos A.; Escallada R.; Echevarra S.; Pastor J.M.; Ruiz J.C.; de Francisco A.L.M.; Cotorruelo J.G.; Fleitas M.G.; Arias M.

Lack of accommodation after long-term survival of hamster xenografts in rats
pp. 2633-2634(2)
Authors: Ribas Y.; Mollev D.G.; Mestre M.; Vidal A.; Berenguer C.; Gonzalez R.; Figueras J.; Jaurrieta E.; Maneznez R.

Identification of porcine proteins in baboon sera after pig liver xenotransplantation
pp. 2635-2637(3)
Authors: Minguela A.; Ramrez P.; Carrascosa C.; Majado M.J.; Munitiz V.; Hernandez Q.; Loba M.; Munoz A.; Chavez R.; Alvarez-Lopez M.R.; Sanchez-Bueno F.; Parrilla P.

Peripheral blood cell subsets in baboon recipients of porcine liver xenotransplantation
pp. 2638-2640(3)
Authors: Minguela A.; Ramrez P.; Majado M.J.; Hernandez Q.; Munitiz V.; Loba M.; Munoz A.; Alvarez-Lopez M.R.; Chavez R.; Pino G.; Robles R.; Parrilla P.

Hematologic and hepatic function profile comparison between pig and baboon in an orthotopic liver xenotransplantation model
pp. 2641-2642(2)
Authors: Muntiz V.; Ramrez P.; Hernandez Q.; Loba M.; Chavez R.; Munoz A.; Ros A.; Minguela A.; Parrilla P.

Early cellular rejection of pig kidney perfused with manipulated human blood to avoid hyperacute rejection1
pp. 2643-2644(2)
Authors: Vega A.; Ramos A.; Val F.; Lopez-Hoyos M.; Ruiz J.C.; de Francisco A.L.M.; Castillo J.; Fleitas M.G.; Arias M.

Quality of life in renal, hepatic, and heart transplant patients
pp. 2647-2648(2)
Authors: Insense B.; Vilardell J.; Aranzabal J.; Lago A.M.

Is IgA nephropathy in renal transplants a risk leading to graft failure?
pp. 2651-2654(4)
Authors: Sakurai T.; Okamoto N.; Fukazawa S.; Sirosita K.; Ueda T.; Hirano T.

Histopathologic findings in routine biopsies of renal transplant allografts
pp. 2655-2658(4)
Authors: Toki K.; Kyo M.; Takahara S.; Hatori M.; Morozumi K.; Ichimaru N.; Wang J.-D.; Ding X.-Q.; Miyamoto M.; Oka K.; Kyakuno M.; Kojima Y.; Kokado Y.; Okuyama A.

The site of absorption of cyclosporin A in the small intestine of the rat: a preliminary report
pp. 2659-2660(2)
Authors: Ogino Y.; Kobayashi E.; Kita J.; Fujimura A.; Kogure H.

Immunologic changes in heterotopic and orthotopic small bowel transplantation in rats
pp. 2661-2664(4)
Authors: Nakai T.; Kawabe T.; Kurooka K.; Okuno K.

The fate of donor splenic lymphocytes in a long-surviving host after combined pancrea/spleen transplantation in the rat
pp. 2665-2667(3)
Authors: Kobayashi E.; Lord R.; Green M.; Kamada N.; Toyama N.; Miyata M.; Fujimura A.

Decreased expression of receptors for vascular endothelial growth factor and sinusoidal endothelial cell damage in cold-preserved rat livers
pp. 2668-2672(5)
Authors: Arai S.; Mochida S.; Ohno A.; Ishikawa K.; Matsui A.; Arai M.; Shibuya M.; Fujiwara K.

Incidence of allograft rejection after corneal transplantation using optisol-preserved corneas in mice
pp. 2673-2674(2)
Authors: Kamiya K.; Hori J.; Obata H.; Yamagami S.; Tsuru T.

Antibody therapy as an induction regimen in pediatric renal transplantation
pp. 2677-2678(2)
Author: Ettenger R.B.